A point mutational analysis of human papillomavirus type 16 E7 protein - PubMed (original) (raw)

A point mutational analysis of human papillomavirus type 16 E7 protein

C Edmonds et al. J Virol. 1989 Jun.

Abstract

The E7 open reading frame of human papillomavirus type 16 (HPV16) has been shown to be selectively retained in cervical tumors and to encode both transforming and trans-activating functions in murine cells, supporting the notion that expression of E7 contributes towards the progression of premalignant cervical lesions. A comparison among E7 sequences of different HPV types reveals some homology at the amino acid level. Of particular interest are two regions, one which contains significant homology to a region of adenovirus E1a and simian virus 40 large T (LT), and a second region which contains two conserved Cys-X-X-Cys motifs. To determine the importance of these domains to the function of the E7 protein, a series of mutants carrying substitutions at amino acids in the region of E1a-LT homology and at the Cys-X-X-Cys motifs were constructed. The mutated E7 sequences were placed under the control of a strong heterologous promoter (Moloney long terminal repeat), and the activity of the mutants was assayed in NIH 3T3 cells, a cell line in which both the transforming function and the trans-activating function of E7 could be determined. A single amino acid substitution analogous to a mutation in E1a which destroys the transforming ability of this protein abolished both transformation and trans-activation by E7. Mutations at the Cys-X-X-Cys motifs demonstrated that this region contributes to the transforming potential of E7, although proteins in which both motifs were interrupted retained a low level of transforming activity. Mutations in the region of E1a-LT homology which occur within a recognition sequence for casein kinase II did not markedly affect transforming activity of E7 but severely reduced trans-activating ability. This indicates that efficient trans-activation is not required for transformation by HPV16 E7 in these cells.

PubMed Disclaimer

Similar articles

• Analysis of human papillomavirus type 16 open reading frame E7 immortalizing function in rat embryo fibroblast cells.
  Chesters PM, Vousden KH, Edmonds C, McCance DJ. Chesters PM, et al. J Gen Virol. 1990 Feb;71 ( Pt 2):449-53. doi: 10.1099/0022-1317-71-2-449. J Gen Virol. 1990. PMID: 2155297
• The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.
  Barbosa MS, Edmonds C, Fisher C, Schiller JT, Lowy DR, Vousden KH. Barbosa MS, et al. EMBO J. 1990 Jan;9(1):153-60. doi: 10.1002/j.1460-2075.1990.tb08091.x. EMBO J. 1990. PMID: 2153075 Free PMC article.
• Mutational analysis of human papillomavirus type 16 E7 functions.
  Watanabe S, Kanda T, Sato H, Furuno A, Yoshiike K. Watanabe S, et al. J Virol. 1990 Jan;64(1):207-14. doi: 10.1128/JVI.64.1.207-214.1990. J Virol. 1990. PMID: 2152813 Free PMC article.
• Molecular mechanisms of transformation by the human papillomaviruses.
  Howley PM, Münger K, Werness BA, Phelps WC, Schlegel R. Howley PM, et al. Princess Takamatsu Symp. 1989;20:199-206. Princess Takamatsu Symp. 1989. PMID: 2562182 Review.
• Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
  Howley PM, Münger K, Romanczuk H, Scheffner M, Huibregtse JM. Howley PM, et al. Princess Takamatsu Symp. 1991;22:239-48. Princess Takamatsu Symp. 1991. PMID: 1668886 Review.

Cited by

• Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor.
  Todorovic B, Hung K, Massimi P, Avvakumov N, Dick FA, Shaw GS, Banks L, Mymryk JS. Todorovic B, et al. J Virol. 2012 Dec;86(24):13313-23. doi: 10.1128/JVI.01637-12. Epub 2012 Sep 26. J Virol. 2012. PMID: 23015707 Free PMC article.
• Simian virus 40 small t antigen trans activates the adenovirus E2A promoter by using mechanisms distinct from those used by adenovirus E1A.
  Loeken MR. Loeken MR. J Virol. 1992 Apr;66(4):2551-5. doi: 10.1128/JVI.66.4.2551-2555.1992. J Virol. 1992. PMID: 1532215 Free PMC article.
• Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways.
  Müller C, Alunni-Fabbroni M, Kowenz-Leutz E, Mo X, Tommasino M, Leutz A. Müller C, et al. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7276-81. doi: 10.1073/pnas.96.13.7276. Proc Natl Acad Sci U S A. 1999. PMID: 10377405 Free PMC article.
• Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
  Peng S, Ferrall L, Gaillard S, Wang C, Chi WY, Huang CH, Roden RBS, Wu TC, Chang YN, Hung CF. Peng S, et al. mBio. 2021 Jan 19;12(1):e03224-20. doi: 10.1128/mBio.03224-20. mBio. 2021. PMID: 33468698 Free PMC article.
• Human papillomaviruses and the interferon response.
  Beglin M, Melar-New M, Laimins L. Beglin M, et al. J Interferon Cytokine Res. 2009 Sep;29(9):629-35. doi: 10.1089/jir.2009.0075. J Interferon Cytokine Res. 2009. PMID: 19715460 Free PMC article. Review.

References

1. 1. Cell. 1986 Sep 26;46(7):1043-51 - PubMed
2. 1. Lancet. 1986 Aug 30;2(8505):489-91 - PubMed
3. 1. EMBO J. 1986 Sep;5(9):2285-92 - PubMed
4. 1. Mol Cell Biol. 1986 Oct;6(10):3470-80 - PubMed
5. 1. J Virol. 1987 Apr;61(4):962-71 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database